496704506	496704506	CD	B-NP	O
|	|	NN	I-NP	O
LH	LH	NN	I-NP	O
|	|	NN	I-NP	O
73953255	73953255	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7917439	7917439	CD	B-NP	O
|	|	CC	I-NP	O
2/22/2005	2/22/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
SHORTNESS	SHORTNESS	NNP	I-NP	I-protein
OF	OF	IN	B-PP	I-protein
BREATH	BREATH	NNP	B-NP	O
,	,	,	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/22/2005	11/22/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/25/2005	7/25/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
ROMAN	ROMAN	NNP	B-NP	O
DAMIAN	DAMIAN	NNP	I-NP	O
GIRGIS	GIRGIS	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADMITTING	ADMITTING	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
56-year-old	56-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
nonischemic	nonischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
recently	recently	RB	B-VP	O
estimated	estimate	VBN	I-VP	O
at	at	IN	B-PP	O
10-15	10-15	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
polysubstance	polysubstance	NN	B-NP	O
abuse	abuse	NN	I-NP	O
including	include	VBG	B-PP	O
IV	IV	CD	B-NP	O
drug	drug	NN	I-NP	O
abuse	abuse	NN	I-NP	O
,	,	,	O	O
internasal	internasal	JJ	B-NP	O
cocaine	cocaine	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
depression	depression	NN	B-NP	O
,	,	,	O	O
celiac	celiac	JJ	B-NP	O
sprue	sprue	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
1.8-2	1.8-2	CD	B-NP	O
.4	.4	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
bipolar	bipolar	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
non-ST	non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
10/29	10/29	CD	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
after	after	IN	B-PP	O
sustaining	sustain	VBG	B-VP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
lives	live	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
floor	floor	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
building	building	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
difficulty	difficulty	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
up	up	RP	B-PRT	O
steps	step	NNS	B-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
walking	walk	VBG	I-VP	O
up	up	RP	B-PRT	O
steps	step	NNS	B-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
increasing	increase	VBG	I-VP	O
dyspneic	dyspneic	JJ	B-NP	O
and	and	CC	I-NP	O
secondary	secondary	JJ	I-NP	O
experience	experience	NN	I-NP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O
.	.	.	O	O

EMS	EMS	NNS	B-NP	O
was	be	VBD	B-VP	O
notified	notify	VBN	I-VP	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Hey	Hey	NNP	I-NP	O
County	County	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
presentation	presentation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Sman	Sman	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
reports	report	VBZ	B-VP	O
other	other	JJ	B-NP	O
additional	additional	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
including	include	VBG	B-PP	O
progressive	progressive	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
and	and	CC	I-NP	O
cough	cough	NN	I-NP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
yellow	yellow	JJ	B-NP	O
phlegm	phlegm	NN	I-NP	O
dating	date	VBG	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
most	most	RBS	B-NP	O
recent	recent	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
from	from	IN	B-PP	O
hospital	hospital	NN	B-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2004	2004	CD	B-NP	O
when	when	WRB	B-ADVP	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
similar	similar	JJ	B-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
,	,	,	I-NP	O
multiple	multiple	JJ	I-NP	O
admissions	admission	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
year	year	NN	I-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
years	year	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
with	with	IN	B-PP	O
exacerbations	exacerbation	NNS	B-NP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
medication	medication	NN	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
dietary	dietary	JJ	B-NP	O
discretion	discretion	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
stated	state	VBN	B-VP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Include	Include	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Regular	Regular	NNP	B-NP	O
Insulin	Insulin	NNP	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
insomnia	insomnia	NN	I-NP	O
,	,	,	O	O
spironolactone	spironolactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
amlodipine	amlodipine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
15	15	CD	I-NP	O
units	unit	NNS	I-NP	O
SC	SC	NNP	B-NP	O
q.h.s.	q.h.s.	NNP	I-NP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
allergies	allergy	NNS	B-NP	O
to	to	TO	B-PP	O
multiple	multiple	JJ	B-NP	O
medications	medication	NNS	I-NP	O
including	include	VBG	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
codeine	codeine	NN	B-NP	O
,	,	,	O	O
tetracycline	tetracycline	NN	B-NP	O
,	,	,	O	O
NSAIDs	NSAID	NNS	B-NP	O
,	,	,	O	O
ibuprofen	ibuprofen	NN	B-NP	O
,	,	,	O	O
Benadryl	Benadryl	NN	B-NP	O
,	,	,	O	O
Compazine	Compazine	NN	B-NP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
receive	receive	VB	I-VP	O
beta-blockage	beta-blockage	NN	B-NP	O
given	give	VBN	I-NP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
cocaine	cocaine	NN	B-NP	O
abuse	abuse	NN	I-NP	O
and	and	CC	O	O
ongoing	ongoing	JJ	B-NP	O
cocaine	cocaine	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
lives	live	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
floor	floor	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
apartment	apartment	NN	I-NP	O
building	building	NN	I-NP	O
.	.	.	O	O

Former	Former	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
user	user	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
refused	refuse	VBD	B-VP	O
to	to	TO	I-VP	O
discuss	discuss	VB	I-VP	O
polysubstance	polysubstance	NN	B-NP	O
abuse	abuse	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
at	at	IN	B-PP	O
96	96	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
of	of	IN	B-PP	O
84	84	NN	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
150/99	150/99	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
combative	combative	JJ	I-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
exactly	exactly	RB	B-ADVP	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
agitation	agitation	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
with	with	IN	B-PP	O
pulsation	pulsation	NN	B-NP	O
observant	observant	JJ	B-ADJP	O
the	the	DT	B-NP	O
ear	ear	NN	I-NP	O
at	at	IN	B-PP	O
90	90	CD	B-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
estimated	estimate	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
18	18	CD	I-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
addition	addition	NN	I-NP	O
with	with	IN	B-PP	O
rales	rale	NNS	B-NP	O
approximately	approximately	RB	B-ADJP	O
one-half	one-half	RB	I-ADJP	O
to	to	TO	B-PP	O
two-thirds	two-third	NNS	B-NP	O
up	up	RB	B-ADVP	O
bilaterally	bilaterally	RB	B-ADVP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
were	be	VBD	B-VP	O
appropriated	appropriate	VBN	I-VP	O
.	.	.	O	O

Patient	Patient	NNP	B-NP	O
's	's	POS	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
well-perfused	well-perfused	JJ	I-ADJP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hips	hip	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
VALUES	VALUES	VBZ	B-VP	O
ON	ON	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
127	127	CD	B-NP	O
,	,	,	O	O
hyponatremia	hyponatremia	NN	B-NP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
chronic	chronic	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
of	of	IN	B-PP	O
5.1	5.1	CD	B-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
of	of	IN	B-PP	O
19	19	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
2.6	2.6	CD	B-NP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
377	377	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
34.5	34.5	CD	B-NP	O
and	and	CC	O	O
BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
at	at	IN	B-PP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
80	80	CD	I-NP	O
with	with	IN	B-PP	O
T-wave	T-wave	JJ	B-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
V5-V6	V5-V6	NN	B-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
prior	prior	JJ	B-NP	O
echocardiograms	echocardiogram	NNS	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
congestion	congestion	NN	I-NP	O
with	with	IN	B-PP	O
flank	flank	NN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
was	be	VBD	B-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

As	As	IN	B-PP	O
such	such	JJ	B-NP	O
,	,	,	I-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
and	and	CC	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
medication	medication	NN	B-NP	O
and	and	CC	O	O
dietary	dietary	JJ	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
as	as	IN	B-SBAR	O
previously	previously	RB	B-ADVP	O
mentioned	mention	VBN	B-VP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
A.	A.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
ischemic	ischemic	JJ	B-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
not	not	RB	O	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
recurrent	recurrent	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
but	but	CC	O	O
rather	rather	RB	B-ADVP	O
medication	medication	NN	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
prior	prior	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
leaks	leak	NNS	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
0.10	0.10	CD	B-NP	O
to	to	TO	B-PP	O
0.12	0.12	CD	B-NP	O
on	on	IN	B-PP	O
prior	prior	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
.	.	.	O	O

Not	Not	RB	O	O
felt	feel	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
ischemia	ischemia	NN	B-NP	O
necessarily	necessarily	RB	B-ADVP	O
but	but	CC	I-ADVP	O
rather	rather	RB	I-ADVP	O
due	due	JJ	B-ADJP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
elevated	elevate	VBN	B-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
not	not	RB	O	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
state	state	NN	I-NP	O
but	but	CC	O	O
rather	rather	RB	B-ADVP	O
just	just	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
using	use	VBG	B-VP	O
both	both	CC	O	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	O	O
p.o.	p.o.	FW	B-NP	O
torsemide	torsemide	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
relatively	relatively	RB	B-ADJP	O
euvolemic	euvolemic	JJ	I-ADJP	O
though	though	IN	B-SBAR	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
require	require	VB	I-VP	O
further	far	JJR	B-NP	O
outpatient	outpatient	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	O	O
ongoing	ongoing	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
continued	continue	VBN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
adhering	adhere	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
2	2	CD	I-NP	O
liter	liter	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
fluid-restriction	fluid-restriction	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
would	would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
further	further	JJ	B-NP	O
nutritional	nutritional	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	I-NP	O
counseling	counseling	NN	I-NP	O
regarding	regard	VBG	B-VP	O
his	his	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
status	status	NN	I-NP	O
given	give	VBN	B-VP	O
poor	poor	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
with	with	IN	B-PP	O
relatively	relatively	RB	B-NP	O
good	good	JJ	I-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
and	and	CC	I-NP	O
I/O	I/O	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
negative	negative	JJ	I-NP	O
0.5	0.5	CD	I-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
kg	kg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
would	would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
intensive	intensive	JJ	B-NP	O
outpatient	outpatient	NN	I-NP	O
CHF	CHF	NN	I-NP	O
management	management	NN	I-NP	O
including	include	VBG	B-PP	O
multidisciplinary	multidisciplinary	JJ	B-NP	O
approach	approach	NN	I-NP	O
using	use	VBG	B-VP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
nursing	nursing	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
advised	advise	VBD	B-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
scale	scale	NN	B-NP	O
and	and	CC	I-NP	O
record	record	NN	I-NP	O
daily	daily	JJ	I-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
issues	issue	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
with	with	IN	B-PP	O
compliance	compliance	NN	B-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
Aldactone	Aldactone	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
and	and	CC	O	O
instead	instead	RB	B-ADVP	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Isordil/hydralazine	Isordil/hydralazine	NN	B-NP	O
for	for	IN	B-PP	O
hemodynamic	hemodynamic	JJ	B-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

C.	C.	NNP	B-NP	O
Rhythm	Rhythm	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
perspective	perspective	NN	I-NP	O
,	,	,	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
monitoring	monitor	VBG	B-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
events	event	NNS	I-NP	O
over	over	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
elevated	elevate	VBD	B-VP	O
to	to	TO	B-PP	O
2.6	2.6	CD	B-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
ongoing	ongoing	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	O	O
correction	correction	NN	B-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
corrected	correct	VBN	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
value	value	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

Recommend	Recommend	VB	B-VP	O
rehab	rehab	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
including	include	VBG	B-PP	O
creatinine	creatinine	NN	B-NP	O
and	and	CC	I-NP	O
BUN	BUN	NN	I-NP	O
every	every	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
until	until	IN	B-PP	O
patient	patient	NN	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
,	,	,	O	O
given	give	VBN	B-PP	O
concern	concern	NN	B-NP	O
or	or	CC	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
during	during	IN	B-PP	O
ongoing	ongoing	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
with	with	IN	B-PP	O
Regular	Regular	NNP	B-NP	O
Insulin	Insulin	NNP	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
per	per	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
bipolar	bipolar	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
Depakote	Depakote	NNP	B-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insomnia	insomnia	NN	B-NP	O
managed	manage	VBD	B-VP	O
with	with	IN	B-PP	O
Ativan	Ativan	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
Patient	Patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
bipolar	bipolar	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Depakote	Depakote	NN	B-NP	O
per	per	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	VBP	B-VP	O
TIME	TIME	NN	B-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
hydralazine	hydralazine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
hold	hold	NN	I-NP	O
parameter	parameter	NN	I-NP	O
for	for	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
mmHg	mmHg	NN	I-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
Insulin	Insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
,	,	,	O	O
Norvasc	Norvasc	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
given	give	VBN	B-NP	O
aspirin	aspirin	NN	I-NP	O
allergy	allergy	NN	I-NP	O
,	,	,	O	O
Depakote	Depakote	NN	B-NP	O
ER	ER	NN	I-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
with	with	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
substitution	substitution	NN	I-NP	O
for	for	IN	B-PP	O
formulary	formulary	JJ	B-NP	O
PPI	PPI	NNP	I-NP	O
,	,	,	I-NP	O
Lantus	Lantus	NNP	I-NP	O
20	20	CD	I-NP	O
units	unit	NNS	I-NP	O
SC	SC	NNP	B-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
P.r.n.	P.r.n.	NNP	I-NP	O
medications	medication	NNS	I-NP	O
to	to	TO	B-VP	O
include	include	VB	I-VP	O
Tylenol	Tylenol	NNP	B-NP	O
,	,	,	I-NP	O
Ativan	Ativan	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
insomnia	insomnia	NNP	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
neb	neb	NN	I-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
neb	neb	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
Ultram	Ultram	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

ONGOING	ONGOING	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
ISSUES	ISSUES	NNPS	I-NP	O
AND	AND	NNP	I-NP	O
OUTPATIENT	OUTPATIENT	NNP	I-NP	O
ISSUES	ISSUES	NNPS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
further	far	JJR	B-NP	O
aggressive	aggressive	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
CHF	CHF	NN	I-NP	O
management	management	NN	I-NP	O
including	include	VBG	B-PP	O
ongoing	ongoing	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
using	use	VBG	B-VP	O
p.o.	p.o.	FW	B-NP	O
torsemide	torsemide	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
does	do	VBZ	B-VP	O
put	put	VB	I-VP	O
out	out	RP	B-PRT	O
well	well	RB	B-ADVP	O
to	to	TO	B-VP	O
p.o.	p.o.	VB	I-VP	O
torsemide	torsemide	NN	B-NP	O
,	,	,	O	O
though	though	IN	O	O
of	of	IN	B-PP	O
note	note	NN	B-NP	O
he	he	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
compliance	compliance	NN	B-NP	O
issues	issue	NNS	I-NP	O
with	with	IN	B-PP	O
regards	regard	NNS	B-NP	O
to	to	TO	B-PP	O
daily	daily	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
would	would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
further	further	JJ	B-NP	O
titration	titration	NN	I-NP	O
of	of	IN	B-PP	O
hydralazine	hydralazine	NN	B-NP	O
and	and	CC	I-NP	O
Isordil	Isordil	NN	I-NP	O
to	to	TO	B-VP	O
maximize	maximize	VB	I-VP	O
hemodynamic	hemodynamic	JJ	B-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
peak	peak	JJ	B-NP	O
potassium	potassium	NN	I-NP	O
reaching	reach	VBG	B-VP	O
6.0	6.0	CD	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
and	and	CC	I-NP	O
spironolactone	spironolactone	NN	I-NP	O
held	hold	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Would	Would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
reinstitution	reinstitution	NN	B-NP	O
of	of	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
particularly	particularly	RB	B-ADVP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
with	with	IN	B-PP	O
low-dose	low-dose	JJ	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
perhaps	perhaps	RB	B-VP	O
starting	start	VBG	I-VP	O
at	at	IN	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
with	with	IN	B-PP	O
intensive	intensive	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
of	of	IN	B-PP	O
potassium	potassium	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
would	would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
further	further	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
teaching	teaching	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
given	give	VBN	I-NP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
poor	poor	JJ	I-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Strongly	Strongly	RB	B-ADVP	O
feel	feel	NN	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
involvement	involvement	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
program	program	NN	I-NP	O
either	either	CC	B-PP	O
through	through	IN	B-PP	O
Gon	Gon	NNP	B-NP	O
Ce	Ce	NNP	I-NP	O
or	or	CC	B-PP	O
through	through	IN	B-PP	O
other	other	JJ	B-NP	O
program	program	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
APPOINTMENT	APPOINTMENT	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Marion	Marion	NNP	I-NP	O
Salser	Salser	NNP	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Pressou	Pressou	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
call	call	VBP	B-VP	O
for	for	IN	B-PP	O
follow-up	follow-up	JJ	B-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-7655779	2-7655779	CD	B-NP	O
LMSSten	LMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ROCHE	ROCHE	NNP	B-NP	O
,	,	,	O	O
ALEXANDER	ALEXANDER	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ARY	ARY	NNP	B-NP	O
,	,	,	O	O
COLTON	COLTON	NNP	B-NP	O
LOUIE	LOUIE	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
4254822	4254822	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
8/7/05	8/7/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/7/05	8/7/05	CD	B-NP	O

